While it may not be enough for some shareholders, we think it is good to see the Medtronic plc ( NYSE:MDT ) share ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Shares of Medtronic PLC MDT slumped 0.56% to $88.13 Wednesday, on what proved to be an all-around dismal trading session for ...

Urology Week 2024, which closes out Urology Awareness Month, is a good time to highlight the innovations in this space.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...

According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies ...